Home/Filings/4/0001179110-17-000397
4//SEC Filing

CymaBay Therapeutics, Inc. 4

Accession 0001179110-17-000397

CIK 0001042074operating

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:09 PM ET

Size

5.6 KB

Accession

0001179110-17-000397

Insider Transaction Report

Form 4
Period: 2016-12-30
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-12-30+21,00021,000 total
    Exercise: $1.82From: 2016-12-30Exp: 2026-07-24Common Stock (21,000 underlying)
Footnotes (1)
  • [F1]On July 25, 2016, the Reporting Person was granted an option to purchase 42,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met, resulting in vesting of the option as to 21,000 shares.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001042074

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:09 PM ET
Size
5.6 KB